Renata Pasqualini
Overview
Explore the profile of Renata Pasqualini including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
219
Citations
7020
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kra J, Markosian C, Tang F, de Leon A, Chundury A, Agarwalla P, et al.
Brain Pathol
. 2025 Jan;
e13331.
PMID: 39838550
Oxidized regenerated cellulose (ORC; marketed as Surgicel® and Tabotamp®) is routinely used as an intraoperative hemostatic agent. Rarely, residual ORC has been associated with a foreign body reaction generating cystic...
2.
Ille A, Markosian C, Burley S, Pasqualini R, Arap W
bioRxiv
. 2024 Dec;
PMID: 39677766
Protein structure prediction artificial intelligence/machine learning (AI/ML) approaches has sparked substantial research interest in structural biology and adjacent disciplines. More recently, AlphaFold2 (AF2) has been adapted for the prediction of...
3.
Ille A, Markosian C, Burley S, Mathews M, Pasqualini R, Arap W
Sci Rep
. 2024 Aug;
14(1):19372.
PMID: 39169047
Natural language-based generative artificial intelligence (AI) has become increasingly prevalent in scientific research. Intriguingly, capabilities of generative pre-trained transformer (GPT) language models beyond the scope of natural language tasks have...
4.
Ille A, Markosian C, Burley S, Mathews M, Pasqualini R, Arap W
bioRxiv
. 2024 Jan;
PMID: 38293060
Natural language-based generative artificial intelligence (AI) has become increasingly prevalent in scientific research. Intriguingly, capabilities of generative pre-trained transformer (GPT) language models beyond the scope of natural language tasks have...
5.
Butner J, Dogra P, Chung C, Pasqualini R, Arap W, Lowengrub J, et al.
Nat Comput Sci
. 2023 Dec;
2(12):785-796.
PMID: 38126024
Encouraging advances are being made in cancer immunotherapy modeling, especially in the key areas of developing personalized treatment strategies based on individual patient parameters, predicting treatment outcomes and optimizing immunotherapy...
6.
Staquicini D, Cardo-Vila M, Rotolo J, Staquicini F, Tang F, Smith T, et al.
Proc Natl Acad Sci U S A
. 2023 Aug;
120(34):e2220269120.
PMID: 37579172
The vascular endothelium from individual organs is functionally specialized, and it displays a unique set of accessible molecular targets. These serve as endothelial cell receptors to affinity ligands. To date,...
7.
Cararo Lopes E, Sawant A, Moore D, Ke H, Shi F, Laddha S, et al.
Clin Transl Med
. 2023 Jun;
13(6):e1298.
PMID: 37317665
Background: Differentiated thyroid cancer (DTC) affects thousands of lives worldwide each year. Typically, DTC is a treatable disease with a good prognosis. Yet, some patients are subjected to partial or...
8.
Andrade W, Tang F, Mariotti A, Mancini M, Duarte I, Singer E, et al.
Sci Rep
. 2023 Jun;
13(1):9237.
PMID: 37286592
Kidney cancer is a common urologic malignancy with either laparoscopic (LPN) or robotic partial nephrectomy as therapeutic options of choice for localized tumors. However, renal resection and suturing are challenging...
9.
Lubin J, Markosian C, Balamurugan D, Ma M, Chen C, Liu D, et al.
JCI Insight
. 2023 Jun;
8(13).
PMID: 37261904
Given the COVID-19 pandemic, there is interest in understanding ligand-receptor features and targeted antibody-binding attributes against emerging SARS-CoV-2 variants. Here, we developed a large-scale structure-based pipeline for analysis of protein-protein...
10.
Dogra P, Schiavone C, Wang Z, Ruiz-Ramirez J, Caserta S, Staquicini D, et al.
JCI Insight
. 2023 May;
8(13.
PMID: 37227783
While the development of different vaccines slowed the dissemination of SARS-CoV-2, the occurrence of breakthrough infections has continued to fuel the COVID-19 pandemic. To secure at least partial protection in...